<DOC>
	<DOC>NCT00566865</DOC>
	<brief_summary>The primary objective of this study is to determine the extent of effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of mitiglinide.</brief_summary>
	<brief_title>Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>nonsmoker Body mass index (BMI) of 1928 kg/m2 no relevant food allergies any subject for whom gemfibrozil is contraindicated any subject with a history of hypoglycemia or who tend to get easily hypoglycemic clinically significant history of or current abnormality or disease of any organ system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>